|
HSPD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.596600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559010E-01 |
| Normal-vs-Stage2 |
7.081000E-01 |
| Normal-vs-Stage3 |
5.864300E-02 |
| Normal-vs-Stage4 |
2.686400E-01 |
| Stage1-vs-Stage2 |
1.226020E-01 |
| Stage1-vs-Stage3 |
1.199230E-01 |
| Stage1-vs-Stage4 |
6.420000E-01 |
| Stage2-vs-Stage3 |
2.417800E-02 |
| Stage2-vs-Stage4 |
3.119400E-01 |
| Stage3-vs-Stage4 |
1.460970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.007210E-01 |
| Normal-vs-AfricanAmerican |
2.549200E-01 |
| Normal-vs-Asian |
2.487000E-01 |
| Caucasian-vs-AfricanAmerican |
3.469800E-01 |
| Caucasian-vs-Asian |
3.977000E-01 |
| AfricanAmerican-vs-Asian |
9.564000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.298240E-01 |
| Normal-vs-Female |
1.790820E-01 |
| Male-vs-Female |
5.315200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.538050E-01 |
| Normal-vs-Age(41-60Yrs) |
1.035360E-01 |
| Normal-vs-Age(61-80Yrs) |
3.236400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.706200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.556000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.919610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.434970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.116800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.609700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.309800E-01 |
| Classical-VS-Follicular |
7.229800E-01 |
| Classical-VS-Other |
3.854000E-01 |
| Classical-VS-Normal |
1.834560E-01 |
| Tall-VS-Follicular |
4.151400E-01 |
| Tall-VS-Other |
5.460800E-01 |
| Tall-VS-Normal |
1.206790E-01 |
| Follicular-VS-Other |
4.848600E-01 |
| Follicular-VS-Normal |
2.862200E-01 |
| Other-VS-Normal |
8.501700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.453010E-01 |
| Normal-vs-N1 |
4.819700E-02 |
| N0-vs-N1 |
2.230000E-01 |
|
|
